市場調查報告書

持續血糖監測系統 (CGM) 設備的全球市場 - 市場佔有率,市場規模,趨勢,產業分析,及未來預測

Continuous Glucose Monitoring Market Share, Size, Trends, & Industry Analysis Report, By Components type, By end users ; By Region: Segment Forecast, 2019 - 2025

出版商 Polaris Market Research 商品編碼 817640
出版日期 內容資訊 英文 97 Pages
商品交期: 最快1-2個工作天內
價格
持續血糖監測系統 (CGM) 設備的全球市場 - 市場佔有率,市場規模,趨勢,產業分析,及未來預測 Continuous Glucose Monitoring Market Share, Size, Trends, & Industry Analysis Report, By Components type, By end users ; By Region: Segment Forecast, 2019 - 2025
出版日期: 2019年03月01日內容資訊: 英文 97 Pages
簡介

本報告涵括持續血糖監測系統 (CGM) 設備的全球市場,基於市場規模,成長促進因素及阻礙因素,市場機會,產業趨勢,以及市場競爭情形等廣泛調查,來進行市場現狀分析以及未來預測。同時更提供結構品,各終端用戶,及各地區類別之市場詳細分析與預測。

第1章 市場概要及範圍

  • 調查目的及調查範圍
  • 調查上的估計條件
  • 調查手法
  • 本調查的成果
  • 利害關係者

第2章 摘要整理

  • 市場定義
  • 市場分類

第3章 持續血糖監測系統設備市場預測

  • 持續血糖監測系統設備 - 產業概況
  • 持續血糖監測系統設備 - 生態系統分析
  • 持續血糖監測系統設備市場動態
  • 產業分析 - 波特的五力分析
  • 持續血糖監測系統設備市場PEST分析
  • 持續血糖監測系統設備市場價值鏈分析
  • 持續血糖監測系統設備產業趨勢
  • 競爭力排行榜分析

第4章 持續血糖監測系統設備市場各結構品市場規模及未來預測

  • 重要的調查結果
  • 資料發送器及接收器
  • 感測器
  • 胰島素幫浦
  • 其他

第5章 持續血糖監測系統設備市場各終端用戶市場規模及未來預測

  • 重要的調查結果
  • 醫院
  • 居家醫療診斷
  • 其他

第6章 持續血糖監測系統設備市場各地區市場規模及未來預測

  • 重要的調查結果
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 比利時
    • 俄羅斯
    • 荷蘭
    • 其他的歐洲各國
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 新加坡
    • 馬來西亞
    • 印尼
    • 泰國
    • 菲律賓
    • 其他的亞太地區各國
  • 南美
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他的南美各國
  • 中東及非洲
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 南非
    • 其他的中東·非洲各國

第7章 企業簡介

  • Dexcom Inc.
  • Roche Diagnostics
  • Medtronic plc.
  • Novo Nordisk
  • Abbott Laboratories
  • Animas Corporation
  • Ypsomed AG.
  • Bayer AG
  • Insulet Corporation
  • Sensonic Corporation
目錄
Product Code: PM1608

The global continuous glucose monitoring market size is anticipated to reach USD 1,325.9 million by 2025 growing at a CAGR of 15.8% from 2019 to 2025 according to a new report published by Polaris Market Research. The report 'Continuous Glucose Monitoring (CGM) Market Share, Size, Trends, & Industry Analysis Report, By Components type (Transmitters & Receivers, Sensor, Insulin Pumps), By end users (Hospitals, Homecare Diagnostics, Others); By Region: Segment Forecast, 2019 - 2025' provides insights on the current market scenario and the prospects.

In 2018, by segment type sensors capture the largest market shares in terms of revenue and hold major share in the market. Regionally, North America accounted for the major share in the wearable medical device market.

The market is primarily driven by rising prevalence of diabetes globally and increased calling for glucose level testing instantly. Moreover, this innovative technology allowing quick access for analyzing blood glucose level that will stimulate the entire industry. Additionally, increasing awareness for the use of these devices in the developing countries would also propel CGM market in coming years. Furthermore, rising need for the diagnosis of hyperglycemic and hypoglycemic conditions in an individual, and increasing opportunities in the developing countries with the increasing need of research and development by the key players also support the market growth. However, stringent regulatory policies and expensive systems would hinder the market growth during the forecast period.

On the basis of component type, in 2018, transmitters & receiver holds the major market share. While, sensor component type will be on a leading position during the forecast period. The sensors would hold major share owning to its advantages such as user-friendly technology and increasing awareness for testing blood glucose level in a less time frame.

End users of continuous glucose monitoring are the hospitals, and homecare diagnostics. Homecare diagnostics holds the major share in the CGM market due to, continuous innovations of products that do not require hospital staff intervention for operating these devices.

Geographically, North America holds a dominating position in the global continuous glucose monitoring (CGM) market followed by Europe and Asia Pacific. The growth in the North America wearable medical device market is basically driven growing rate of obesity in this region, sedentary lifestyle rising prevalence of diabetes, and techno savvy population in North America. While, Asia Pacific is poised to grow at a faster rate during the forecast period.

The leading companies operating in this industry include Dexcom Inc., Roche Diagnostics, Medtronic plc., Novo Nordisk, Abbott Laboratories, Animas Corporation, Ypsomed AG., Bayer AG, Insulet Corporation, and Sensonic Corporation.

Key Findings from the study suggest CGM available in the market are continuously concentrating on the technological advancements. The leading companies while developing new systems focusing on the ease of the operation for the patients without hospital staff interventions. Regionally, North America is presumed to dominate the global continuous glucose monitoring market over the forecast years and Asia Pacific region shows signs of high growth owing to the booming economies of India, and China.

Polaris Market Research has segmented the global continuous glucose monitoring market on the basis of component type, end user and region:

Continuous Glucose Monitoring Component Type Outlook (Revenue, USD Million, 2015 - 2025)

Transmitters & Receivers

Sensors

Insulin Pumps

Continuous Glucose Monitoring End User Outlook (Revenue, USD Million, 2015 - 2025)

Hospitals

Homecare Diagnostics

Others

Continuous Glucose Monitoring Regional Outlook (Revenue, USD Million, 2015 - 2025)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Belgium

Russia

Netherlands

Rest of Europe

Asia-Pacific

China

India

Japan

Korea

Singapore

Malaysia

Indonesia

Thailand

Philippines

Rest of Asia-Pacific

Latin America

Brazil

Mexico

Argentina

Rest of LATAM

Middle East & Africa

UAE

Saudi Arabia

South Africa

Rest of MEA

Table of Contents

1. Overview and Scope

  • 1.1. Research goal & scope
  • 1.2. Research assumptions
  • 1.3. Research methodology
    • 1.3.1. Primary data sources
    • 1.3.2. Secondary data sources
  • 1.4. Key take-away
  • 1.5. Stakeholders

2. Executive Summary

  • 2.1. Market definition
  • 2.2. Market segmentation

3. Continuous Glucose Monitoring Device Market Insights

  • 3.1. Continuous Glucose Monitoring - Industry snapshot
    • 3.1.1. Leading Companies
    • 3.1.2. Key Companies to Watch
  • 3.2. Continuous Glucose Monitoring - Ecosystem analysis
    • 3.2.1. Disease overview
    • 3.2.2. Commercial Landscape
  • 3.3. Continuous Glucose Monitoring Market Dynamics
    • 3.3.1. Continuous Glucose Monitoring - Market Forces
      • 3.3.1.1. Continuous Glucose Monitoring Market Driver Analysis
      • 3.3.1.2. Continuous Glucose Monitoring Market Restraint/Challenges analysis
      • 3.3.1.3. Continuous Glucose Monitoring Market Opportunity Analysis
  • 3.4. Industry analysis - Porter's five forces
    • 3.4.1. Bargaining power of supplier
    • 3.4.2. Bargaining power of buyer
    • 3.4.3. Threat of substitute
    • 3.4.4. Threat of new entrant
    • 3.4.5. Degree of competition
  • 3.5. Continuous Glucose Monitoring Market PEST Analysis
  • 3.6. Continuous Glucose Monitoring Market Value Chain Analysis
  • 3.7. Continuous Glucose Monitoring Industry Trends
  • 3.8. Competitive Ranking Analysis, 2017

4. Continuous Glucose Monitoring Market Size and Forecast, 2015 - 2025 by Component Types

  • 4.1. Key Findings
  • 4.2. Transmitters & Receivers
  • 4.3. Sensors
  • 4.4. Insulin Pumps
  • 4.5. Others

5. Continuous Glucose Monitoring Market Size and Forecast, 2015 - 2025 by End Users

  • 5.1. Key Findings
  • 5.2. Hospitals
  • 5.3. Homecare Diagnostics
  • 5.4. Others

6. Continuous Glucose Monitoring Market Size and Forecast, 2015 - 2025 by Region

  • 6.1. Key Findings
  • 6.2. North America
    • 6.2.1. U.S.
    • 6.2.2. Canada
  • 6.3. Europe
    • 6.3.1. Germany
    • 6.3.2. UK
    • 6.3.3. France
    • 6.3.4. Italy
    • 6.3.5. Spain
    • 6.3.6. Belgium
    • 6.3.7. Russia
    • 6.3.8. Netherlands
    • 6.3.9. Rest of Europe
  • 6.4. Asia-Pacific
    • 6.4.1. China
    • 6.4.2. India
    • 6.4.3. Japan
    • 6.4.4. Korea
    • 6.4.5. Singapore
    • 6.4.6. Malaysia
    • 6.4.7. Indonesia
    • 6.4.8. Thailand
    • 6.4.9. Philippines
    • 6.4.10. Rest of Asia-Pacific
  • 6.5. Latin America
    • 6.5.1. Brazil
    • 6.5.2. Mexico
    • 6.5.3. Argentina
    • 6.5.4. Rest of LATAM
  • 6.6. Middle East & Africa
    • 6.6.1. UAE
    • 6.6.2. Saudi Arabia
    • 6.6.3. South Africa
    • 6.6.4. Rest of MEA

7. Company Profiles

  • 7.1. Dexcom Inc.
    • 7.1.1. Overview
    • 7.1.2. Financials
    • 7.1.3. Product Benchmarking
    • 7.1.4. Recent Developments
  • 7.2. Roche Diagnostics
    • 7.2.1. Overview
    • 7.2.2. Financials
    • 7.2.3. Product Benchmarking
    • 7.2.4. Recent Developments
  • 7.3. Medtronic plc.
    • 7.3.1. Overview
    • 7.3.2. Financials
    • 7.3.3. Product Benchmarking
    • 7.3.4. Recent Developments
  • 7.4. Novo Nordisk
    • 7.4.1. Overview
    • 7.4.2. Financials
    • 7.4.3. Product Benchmarking
    • 7.4.4. Recent Developments
  • 7.5. Abbott Laboratories
    • 7.5.1. Overview
    • 7.5.2. Financials
    • 7.5.3. Product Benchmarking
    • 7.5.4. Recent Developments
  • 7.6. Animas Corporation
    • 7.6.1. Overview
    • 7.6.2. Financials
    • 7.6.3. Product Benchmarking
    • 7.6.4. Recent Developments
  • 7.7. Ypsomed AG.
    • 7.7.1. Overview
    • 7.7.2. Financials
    • 7.7.3. Product Benchmarking
    • 7.7.4. Recent Developments
  • 7.8. Bayer AG
    • 7.8.1. Overview
    • 7.8.2. Financials
    • 7.8.3. Product Benchmarking
    • 7.8.4. Recent Developments
  • 7.9. Insulet Corporation
    • 7.9.1. Overview
    • 7.9.2. Financials
    • 7.9.3. Product Benchmarking
    • 7.9.4. Recent Developments
  • 7.10. Sensonic Corporation
    • 7.10.1. Overview
    • 7.10.2. Financials
    • 7.10.3. Product Benchmarking
    • 7.10.4. Recent Developments